• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

docj

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 951-1000 of 5600 result(s).

Board Name	Posts By docj	Post Created
GNBTQ Generex Biotechnology Corp.	Let us know what you find out: Jose (1)	09/17/2021 11:14:15 AM
CYDY CytoDyn Inc	Adding some everyday. Looking forwa	09/17/2021 8:40:53 AM
CYDY CytoDyn Inc	http://newsfile.refinitiv.com/getn (4)	09/17/2021 8:07:15 AM
GNBTQ Generex Biotechnology Corp.	Interesting. I am sure there are pl (1)	09/16/2021 2:53:06 PM
GNBTQ Generex Biotechnology Corp.	For those who sent an email already (1)	09/16/2021 12:49:34 PM
GNBTQ Generex Biotechnology Corp.	Perhaps when his/her work slows dow (3)	09/16/2021 11:19:05 AM
GNBTQ Generex Biotechnology Corp.	By all means get back to work so yo (1)	09/16/2021 10:49:41 AM
GNBTQ Generex Biotechnology Corp.	I hear you. I am personally looking (3)	09/16/2021 10:32:09 AM
GNBTQ Generex Biotechnology Corp.	I appreciate the response as I imag (5)	09/16/2021 10:28:05 AM
GNBTQ Generex Biotechnology Corp.	Let's not be so quick to make judge (1)	09/16/2021 7:09:24 AM
GNBTQ Generex Biotechnology Corp.	What can you tell us about who is b (1)	09/15/2021 10:21:13 PM
CYDY CytoDyn Inc	People in Colorado are generally a (2)	09/15/2021 8:42:27 PM
GNBTQ Generex Biotechnology Corp.	Thanks for your input. What would i (5)	09/15/2021 8:35:33 PM
GNBTQ Generex Biotechnology Corp.	Has Bintai Kinden paid Generex for (1)	09/15/2021 7:29:41 PM
GNBTQ Generex Biotechnology Corp.	Still on GNBT and NGIO websites for (1)	09/15/2021 5:31:36 PM
CYDY CytoDyn Inc	Thank goodness Dr Kelly is there to	09/15/2021 4:32:36 PM
GNBTQ Generex Biotechnology Corp.	Joe is not answering his phone and	09/15/2021 3:37:21 PM
GNBTQ Generex Biotechnology Corp.	Actually, if you go back in time to (1)	09/15/2021 10:07:02 AM
CYDY CytoDyn Inc	7 means you get to go by Kentucky F (2)	09/14/2021 2:34:42 PM
CYDY CytoDyn Inc	Let's see what happens with a compl (4)	09/14/2021 7:05:24 AM
GNBTQ Generex Biotechnology Corp.	I think that may be difficult consi (3)	09/14/2021 6:26:47 AM
GNBTQ Generex Biotechnology Corp.	Strong day for sure. I bet some sho (4)	09/13/2021 9:27:03 PM
GNBTQ Generex Biotechnology Corp.	Well written. As usual. Can I get a (4)	09/13/2021 4:26:48 PM
CYDY CytoDyn Inc	VANCOUVER, Washington, Sept. 13, 20 (2)	09/13/2021 6:00:52 AM
CYDY CytoDyn Inc	His answer probably wasn't false as (1)	09/12/2021 9:00:41 PM
GNBTQ Generex Biotechnology Corp.	Wouldn't an investigation of that n	09/12/2021 6:59:52 PM
CYDY CytoDyn Inc	I reached out to Dr Kelly and Dr NP (3)	09/12/2021 5:40:52 PM
GNBTQ Generex Biotechnology Corp.	Not sure what you mean. I sent Emer (1)	09/12/2021 10:03:02 AM
GNBTQ Generex Biotechnology Corp.	CYDY CEO will be on a Emerging Grow (3)	09/11/2021 2:58:59 PM
CYDY CytoDyn Inc	Interim Brazil results cannot get d (2)	09/11/2021 12:38:46 PM
CYDY CytoDyn Inc	You need something more fun to do a	09/11/2021 7:39:48 AM
GNBTQ Generex Biotechnology Corp.	Today is September the 11th. A somb (7)	09/11/2021 7:25:02 AM
GNBTQ Generex Biotechnology Corp.	Eloquently stated Rich. You get it. (2)	09/11/2021 12:48:53 AM
CRXM Cardium Therapeutics Inc	New Altitrade blog: https://altitra	09/10/2021 8:59:08 PM
CRXM Cardium Therapeutics Inc	Updated presentation from June: htt	09/10/2021 8:55:27 PM
CRXM Cardium Therapeutics Inc	Expecting more filings early next w	09/10/2021 8:54:04 PM
GNBTQ Generex Biotechnology Corp.	MMPJOE is missed. At least the one (2)	09/10/2021 7:31:34 PM
GNBTQ Generex Biotechnology Corp.	A reminder for those who have pendi (5)	09/10/2021 4:52:53 PM
CYDY CytoDyn Inc	Christine finds Dr Pourhassan amusi (2)	09/10/2021 3:33:48 PM
GNBTQ Generex Biotechnology Corp.	You are suggesting the company is w	09/10/2021 11:02:52 AM
CYDY CytoDyn Inc	Weak interest in buying. Will be in	09/10/2021 9:49:26 AM
GNBTQ Generex Biotechnology Corp.	A letter was sent. The group asked (1)	09/10/2021 7:06:24 AM
CYDY CytoDyn Inc	So if you are a 13d member realizin	09/09/2021 7:28:01 AM
CYDY CytoDyn Inc	I am not pro 13d group at this poin (3)	09/08/2021 8:54:37 PM
GNBTQ Generex Biotechnology Corp.	To carry this point even further lo (4)	09/08/2021 11:38:32 AM
GNBTQ Generex Biotechnology Corp.	You make a good point. In what bizz (8)	09/08/2021 11:17:45 AM
GNBTQ Generex Biotechnology Corp.	Generex has an interesting idea of (1)	09/08/2021 11:04:11 AM
GNBTQ Generex Biotechnology Corp.	Not really an answer but perhaps he	09/08/2021 8:33:35 AM
GNBTQ Generex Biotechnology Corp.	Zadie, Welcome to the board! (2)	09/08/2021 7:54:51 AM
CYDY CytoDyn Inc	It would be. It would also be great (3)	09/08/2021 7:39:32 AM

• Next >

62427316242520624247462420446241916624182162417866241753624174862415396241455624142862414246241385624133062412676241204624075562401426239516623947162393476239236623834362382956238272623825262381556237991623796462378966237893623784862378026237801623780062377816237673623757962372246237116623695362357856235579623494062349106234888623465262346076234593

Recent Articles

• SquaredFinancial Boosts Leverage to 1:2000, Enhances Trading Flexibility
• Transforming Trading: iFOREX's Game-Changing Pulse Feature
• Last Call to Participate in the $XPL Token Presale Today
• UK Approves BEYONTTRA for Efforts Against ATTR-CM Disease
• Iveco Group N.V. Prepares for First Quarter Results Reveal
• Siili Solutions Unveils New Stock Options Program for 2025A
• Allot Ltd. Set to Reveal Q1 2025 Financial Insights
• Heimar hf. Announces Share Buyback Update and Details
• TOKEN2049 Dubai Sets New Standard with Sold-Out Event
• Empowering QUBT Shareholders: Your Rights and Legal Options
• Argus Unveils Comprehensive Carbon Service for Global Markets
• Bright Scholar's Q2 Financial Overview: Significant Growth Insights
• Splice Enhances Its Music Creation Tools by Acquiring Spitfire Audio
• Splice's Strategic Acquisition of Spitfire Audio Elevates Music Tech
• Tim Hortons Bake Campaign to Benefit Local Communities
• Alm. Brand A/S's Recent Share Buybacks Overview
• AirNet Technology Inc. Ends Deposit Agreement with JPMorgan
• Man Group PLC Updates on Significant Position in American Axle
• B2PRIME Welcomes New Leadership to Enhance Institutional Services
• Realkredit Danmark A/S Reports Key Prepayment Updates
• BlueFocus Journey to RMB 60 Billion Revenue with AI Innovations
• Alliance Pharma's Compliance with Disclosure Rules Simplified
• Comac Medical Strengthens Leadership with Global Expansion Plans
• Biocon Biologics Advances with CHMP Approval for Denosumab
• Comac Medical Expands Global Reach with New Leadership Team
• Biocon Biologics Advances Bone Health with New Biosimilars
• Embrace EZPaycheck's E941 Feature for Stress-Free Filing
• Understanding CIO Concerns: Security Complexity and Value Issues
• WSPN’s New API Integration Accelerates WUSD Minting Process
• MHP Strengthens European Presence by Acquiring UVESA Majority Stake
• Atos Welcomes Marie de Scorbiac as New Investor Relations Leader
• Danske Bank's Impressive Share Buy-Back Progress in Week 17
• Significant Transactions by Huhtamäki Oyj's CEO Released
• Hanna Kyrki Joins Summa Defence as General Counsel for Growth
• Insightful Update on Dowlais Group's Recent Trading Activity
• Sydbank’s Buyback Program Insights and Transactions Overview
• TORM plc Share Capital Growth from Incentive Program Boost
• Navigating De La Rue's Recent Trading Disclosures
• IPLOOK Revolutionizes Messaging with Innovative iSMS Platform
• Cycuria Therapeutics: Pioneering Innovations in Blood Cancer Therapy
• Sinch Leverages Innovation for Enhanced Customer Communication
• Empowering the Multilingual Internet at the APAC DNS Forum
• Sinch Enhances Global Leadership in Customer Communications
• Allurity Expands European Cybersecurity Reach with Infigo Deal
• Allurity Expands Cybersecurity Portfolio with Infigo Purchase
• EnteroBiotix Showcases Results in Gut Health Innovation
• Novonesis Share Buyback Program: Recent Transactions Overview
• eQ Asset Management Secures $168 Million for New Fund
• Exploring Synaptics' Latest Wi-Fi 7 Innovations for IoT
• Q2 Metals Reports Major Extensions and Winter Program Highlights